11 citations
,
June 1999 in “Seminars in Cutaneous Medicine and Surgery”
This article compares modern hair restoration techniques for androgenic alopecia, focusing on procedure times, labor, and costs, but it does not provide new clinical findings.
November 2025 in “International Society of Hair Restoration Surgery”
This case report describes a 45-year-old male who developed a post-operative infection after hair transplantation, likely due to the reuse of a dull sterile implanterpen, highlighting the need for proper instrument selection and infection control.
4 citations
,
May 2017 in “Hair transplant forum international”
This article discusses the historical development and recent rejuvenation of implanterpens in hair restoration surgery and does not present new research findings.
Hair transplantation moves DHT-resistant follicles from a donor area (back and sides of the scalp) into thinning or bald areas. The transplanted hair is generally permanent, though surrounding native hair can keep thinning.
A user shared their positive experience with a hair transplant in Turkey using the DHI and Sapphire FUE techniques, without taking finasteride or minoxidil post-surgery. They emphasized that transplanted hairs from the donor area are resistant to hair loss, but acknowledged that native hairs might still thin without medication.
Hair cloning is seen as a distant and potentially less relevant solution for hair loss due to its high cost, invasiveness, and the advancement of other treatments like Minoxidil and finasteride. Many believe that by the time hair cloning becomes viable, other less invasive and more effective treatments will be available.
A user shared their experience with a Long Hair DHI Hair Transplant, receiving 2,750 grafts. They plan to continue using Dutasteride and Topical Minoxidil post-surgery.
Promising hair loss treatments in clinical trials include Pyrilutamide, GT20029, CB-03-01, and PP405, with potential market releases between 2027 and 2029. Hair cloning remains experimental and expensive, while existing treatments like finasteride, minoxidil, and microneedling continue to be used.
A permanent hair loss solution could involve reprogramming hair follicles to resist DHT using mRNA and siRNA. However, high costs, safety concerns, and the pharmaceutical industry's preference for ongoing treatments over one-time cures are major obstacles, with finasteride and minoxidil remaining standard treatments.